Cancer Immunotherapy and Arthritis
A new type of therapy called Immunotherapy, is used to treat cancers. It’s been observed that Immunotherapy could lead to an over-activation of the immune system. In Rheumatology we’re seeing an increase in arthritis driven by this activation of the immune system. Dr. Cappelli discusses the questions she and her oncologist colleagues have about why this happens and how do we best evaluate and treat these patients.
In This Video
Dr. Cappelli is an Assistant Professor of Medicine in the Johns Hopkins Division of Rheumatology. Her research focuses on inflammatory arthritis and on the effects of cancer immunotherapy.